Neuro News Roundup: Parkinson or parkinsonian?

Slideshow

Studies also include stem cell transplantation for treatment-refractory MS and aspirin use for headache to lessen the need for rescue medication.

The highlights of new studies in neurology include: a single dose of aspirin, from 500 mg to 1000 mg, may reduce the use of rescue medications in adults with frequent episodic tension-type headache; blood neurofilament light chain (NfL) protein can discriminate between Parkinson disease and atypical parkinsonian disorder; and about half of patients with aggressive, treatment-refractory multiple sclerosis (MS) are free from neurological progression five years after autologous hematopoietic stem cell transplantation (AHSCT).

Related Videos
Jaime Imitol, MD
Prashanth Rajarajan, MD, PhD
Riley Bove, MD
Bruce Bebo, PhD
Susan W. Broner, MD
Thomas F. Scott, MD
Ray Dorsey, MD
Krystyn J. Van Vliet, PhD & Anna Jagielska, PhD, MSc
Svetlana Blitshteyn, MD, FAAN, director and founder of Dysautonomia Clinic
© 2024 MJH Life Sciences

All rights reserved.